Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Restoring Surgeons’ Sense of Touch with Robotic Fingertips
A Europe‑wide EU‑funded consortium called PALPABLE is creating a soft‑robotic fingertip that restores tactile perception for minimally invasive and robotic surgery. The device uses fibre‑optic sensors embedded in a silicone dome to translate tissue deformation into visual stiffness maps, helping surgeons identify tumour margins. A first prototype is slated for surgeon testing in March 2026, with the research programme running through the end of 2026. By converting touch into real‑time visual feedback, the technology aims to bridge the sensory gap introduced by keyhole and robotic procedures.
First Yoboo Lifestyle Pharmacy Illustrates Colruyt Group’s Approach to Health
Colruyt Group opened its first Yoboo Lifestyle Pharmacy in Antwerp, converting the former Apotheek Noorderlaan into a health‑focused retail space. The new pharmacy combines traditional services with all‑day lifestyle coaching, self‑test kits, and a curated selection of supplements and functional...
Nine Years to Diagnosis: The Challenge of Spotting Inflammatory Arthritis and the Role of First Contact Physiotherapists
Inflammatory arthritis often remains undiagnosed for an average of nine years, allowing joint damage and fatigue to accumulate. Clinical guidelines stress a three‑month "window of opportunity" where disease‑modifying drugs can halt progression and even induce remission. In the UK, first‑contact...
Texas EMS Staffing Shortage Causes Shift Change, Forcing Medics to Sleep on Cots During Pilot Program
Fort Worth’s fire department is grappling with a severe EMS staffing shortage, with an attrition rate of 16%—about seven employees leaving each month. The agency now has 360 EMS personnel, 89 positions below its target of 449, and 74 trainees...
Insurance That Covers Male Infertility Procedures Improves Opportunities for Family Building
A new study published in *Urology* shows that states mandating insurance coverage for male infertility procedures, alongside female care, experience six times higher IVF utilization and the greatest number of IVF‑born babies per 100,000 women. Male factor infertility accounts for...
NX-1607
Nurix Therapeutics has launched NX-1607, the first orally bioavailable small‑molecule inhibitor of the immune regulator CBL‑B, into a Phase 1a/1b trial for advanced cancers. CBL‑B modulates activation of T, B and NK cells, and NX-1607 locks the protein in an inactive...
A Dose of Psilocybin Helps Smokers Quit in New Study
Researchers at Johns Hopkins found a single dose of psilocybin dramatically increased smoking cessation rates compared with nicotine patches. In a randomized trial of 82 smokers, 17 of 41 participants who received psilocybin remained abstinent after six months versus four...
First-of-Its-Kind Vaccine Protects Children From Deadly E. Coli Infections
Scientists announced ETVAX, the first oral vaccine that targets enterotoxigenic *E. coli* (ETEC) in children, after a large‑scale trial in The Gambia. The study involved 4,936 infants aged six to 18 months and demonstrated a 48% reduction in moderate‑to‑severe ETEC...
STAT+: Novo Nordisk Is Warned by the FDA for Failing to Report Side Effects Tied to GLP-1 Drugs
Novo Nordisk received an FDA warning letter on March 5, 2026 for failing to report suspected side effects of its GLP‑1 medicines. The violations were uncovered during a 2025 inspection of the company’s facilities and were described as “serious.” The agency warned...
US Vaccine Manufacturers Set to Lose as RFK Pushes for Weaker Vaccine Mandates
The Trump administration, led by Health Secretary Robert F. Kennedy Jr., plans to eliminate over a third of the CDC childhood vaccine schedule, targeting seven of eleven vaccines. The United States, which produces roughly 36% of global vaccine output, could...
Building for Decades: Dubai’s Long Game in Life Sciences
Dubai is positioning itself as a long‑term hub for healthcare and life sciences through two complementary free‑zone clusters – Dubai Healthcare City (DHCC) and Dubai Science Park (DSP). DHCC is undergoing a $1.3 bn expansion that will create six tightly linked...
Smith+Nephew Launches Next-Generation ALLEVYN™ COMPLETE CARE Foam Dressing - Designed for High Performance in Wound Management and Pressure Injury Prevention
Smith+Nephhew has introduced ALLEVYN ♢ COMPLETE CARE, a next‑generation five‑layer foam dressing that combines wound‑management and pressure‑injury prevention technologies. The dressing locks in significantly more exudate than competing foams, blocks over 99% of bacteria, and absorbs up to 93% of mechanical energy...
Validic Announces Integration with Salesforce Health Cloud to Advance Connected Care and Value-Based Engagement
Validic announced a new integration with Salesforce Health Cloud at HIMSS 2026, linking its remote patient monitoring and wearable data platform to the cloud‑based patient engagement system. The partnership delivers HIPAA‑compliant, real‑time device data directly into Health Cloud’s 360‑degree patient...
Africa CDC Eyes Debt Swaps to Plug Health Financing Gaps
Facing steep foreign‑aid cuts and high sovereign debt, Africa CDC is turning to debt‑for‑health swaps to bridge financing gaps. The agency has hired Christoph Benn, a veteran of the Global Fund’s Debt2Health mechanism, to spearhead matchmaking between debtor nations and...
FDA Sets Scope for Attempt To Reduce Manufacturing-Related Approval Rejections
The FDA has defined the scope of pre‑submission facility meetings to curb manufacturing‑related complete response letters that delay drug approvals. It agreed to cover prior production‑site inspections, novel process elements and supply‑chain node strategies, while rejecting topics such as alternative...
Betterness Introduces the Agentic Health and Wellness MCP
Betterness unveiled the Betterness Model Context Protocol (MCP), an agentic infrastructure that lets AI systems coordinate diagnostics, biomarker data, wearable signals, and provider networks. The protocol integrates with major lab partners such as Quest Diagnostics, LabCorp, and BioReference, and offers...
America versus Alzheimer's
A bipartisan call in Washington urges the United States to make curing Alzheimer’s a flagship scientific enterprise. The proposal calls for billions in basic brain research, Medicare coverage for early diagnosis and preventive treatment starting at age 50, and parity...
AI's Evolution Will Revolutionize Healthcare Delivery
On the latest episode of Lifers, I’m joined by @MSFTResearch President @peteratmsr. We dive into the evolution of AI and his bold predictions for the future of healthcare. Timestamps: (00:00) Preview (01:23) Intro (02:54) Evolution from deep neural nets to modern AI (04:30) Demystifying model...
Desert to Discovery: Five Hot Biotechs in Arizona
Arizona's biotech sector is booming, with $3.7 billion invested over the past seven years and a growing pipeline of innovative companies. Nectero Therapeutics secured a $96 million Series D to develop a fast‑track, breakthrough‑designated endovascular treatment for abdominal aortic aneurysms, while Humabiologics obtained...
Chronic Overmedication: The Polypharmacy Waste and Safety Problem
Polypharmacy affects nearly 42 % of adults 65 + taking five or more drugs, with 12 % on ten or more, driving higher pharmacy spend and safety risks. Medicare patients alone incurred about $3 billion in excess drug costs from early refills and oversupply,...
Leapfrog Must Remove Safety Grades From 5 Tenet-Owned Hospitals, Judge Says
Federal judge Donald Middlebrooks ruled that The Leapfrog Group must remove the safety grades it assigned to five Tenet Healthcare hospitals, finding the ratings deceptive and unfair. The grades, which were based on an alternative scoring system after the hospitals...
In the Absence of Objective Measures for ALS, Caregivers Are the Only Witnesses. We Shouldn’t Have To Be.
The ALS Functional Rating Scale‑Revised (ALSFRS‑R) remains the primary tool for tracking disease progression, but its limited granularity misses daily fluctuations and subtle improvements. Caregivers, like the author, become the sole recorders of these nuanced changes, highlighting a critical data...
BioNTech Founders' Exit Needed as Sales Plunge
This morning's BioNTech news strikes me as very odd. Certainly, founder Ugur Sahin and Ozlem Tureci shouldn't feel compelled to run the company forever, and they may not be the right people to manage both the continued decline of Covid-19...
Insightin Health Discloses Its Second Data Security Incident in Two Years (1)
Insightin Health disclosed a March 4 2026 breach that stemmed from a zero‑day flaw in the GoAnywhere file‑transfer tool, allowing an unauthorized actor to access health‑plan data between September 17‑23 2025. The compromised files contained member names, dates of birth, insurance IDs and, in...
Valuing Early-Stage Life Sciences Companies: The Why, the How, and the Impact
Early‑stage life sciences firms face unique valuation challenges due to regulatory, market and scientific uncertainties. Traditional discounted cash flow models are unsuitable, so practitioners rely on risk‑adjusted NPV, market comparables, and venture‑capital exit methods. These valuations influence capital raising, stock‑based...
Finances Drive REH Conversion
Mercy Hospital in Moundridge, Kansas, converted to a Rural Emergency Hospital (REH) on Jan. 1, 2024, swapping inpatient services for 24‑hour emergency care and outpatient offerings. The REH model provides a $3.4 million annual facility payment and 105% of the OPPS rate,...
Texas Firefighters Union Says Rising EMS Demand Shows Need for More Ambulances, Not Fewer Engines
The Grapevine Professional Firefighters Association is challenging the city’s plan to close Engine 1 and replace it with a two‑person squad, arguing the move undermines fire‑suppression capacity. The union cites a 19.8% rise in total emergency calls and a 13.1% increase...
Deaminet 2026: Breakthroughs in Base Editing, Deaminase Biology, and Therapeutic Translation
Deaminet 2026 showcased accelerating advances in base and prime editing, highlighted by rapid Addgene distribution growth and new mechanistic insights such as PE6d’s heightened processivity and ABE8e’s dimer‑driven efficiency. Novel off‑target detection platforms like beCasKAS and Inrich‑seq revealed far more unintended...
BioNTech Founders Launch New Biotech, Eye FDA Acceptance
Sticking with the science. I find that really impressive. BioNTech founders Uğur Şahin and Özlem Türeci are leaving the biotech they founded to start a new one. Maybe by the time they have something for the clinic, the FDA will...
Donna Ockenden to Chair Leeds Maternity Investigation
Former senior midwife Donna Ockenden has been appointed chair of an independent review into Leeds Teaching Hospitals' maternity services, following intense lobbying by bereaved families and MPs. The inquiry, approved by Health Secretary Wes Streeting, will examine care, governance and...
China Is Going After the World's Most Expensive Drugs: Endpoints Signal
China is actively targeting ultra‑expensive gene therapies, challenging the notion that these treatments are immune to price competition. Recent regulatory approvals and centralized procurement initiatives have forced manufacturers to negotiate steep discounts on therapies that once commanded multi‑million‑dollar price tags....
Neighbourhood Care: Taking Preventive Health Checks to the Heart of Communities
The Nottingham City Place‑Based Partnership is rolling out neighbourhood‑focused preventive health services to align with the NHS 10‑Year Plan. By deploying free SISU Health Stations in community hubs such as a deprived suburb, a Boots store and a football fan...
FDA Widens Use of Leucovorin without New Trial Data
The U.S. Food and Drug Administration has approved the generic form of leucovorin, also known as folinic acid, for treating cerebral folate deficiency (CFD). The decision widens the drug’s label despite the absence of new clinical trial data, relying on...
Short Films in Focus: “Endless Sea” With Sam Shainberg
Sam Shainberg’s short film “Endless Sea” follows Carol, a flower‑delivery worker, as she scrambles to pay a $365 co‑pay for life‑saving heart medication, exposing the harsh reality of tiered prescription pricing. Set on a rainy Valentine’s Day, the 17‑minute thriller...
Statement on Biomedical Countermeasures Initiative
BIOTECanada welcomes the launch of the National Research Council of Canada’s Biomedical Countermeasures Initiative, a key component of the federal Defence Industrial Strategy. The program is designed to strengthen Canada’s domestic capacity to develop and manufacture diagnostics, vaccines, and therapeutics...
How Universities Can Close a Critical Healthcare Gap
The United States faces a critical shortage of physician assistants, with only 56 per 100,000 residents nationally and just 36 in California. Universities are stepping in by partnering with regional health systems to create pipeline programs that train PAs directly...
The Infiltrator: Recognizing Cardiac Amyloidosis on Echo
Cardiac amyloidosis affects up to a quarter of people over 80 yet remains largely undiagnosed. Characteristic echocardiographic signs—including thickened walls, restrictive filling patterns, and the apical‑sparing strain signature—allow clinicians to suspect the disease early. Differentiating the three amyloid subtypes on...
Weekly AI and Health Tech Trends for Clinicians
Every week, I track the signals that show where medicine is really going from the latest AI breakthroughs and digital health tools to the cultural shifts redefining patient care. The Medical Futurist Newsletter brings you: ✅ Curated insights on the most impactful...
BBIO, ALNY Surge on Pfizer Tafamidis Patent Win
$BBIO $ALNY moving higher on apparently good news re: Pfizer's tafamidis patent defense. If you have access to Umer Raffat's research, he has all the details.
Psilocybin Plus Therapy Boosts Quit Rates Sixfold
🚨 @NPR spotlights our new JAMA Network Open study: One psilocybin dose + therapy gives 6X better odds of quitting smoking vs. nicotine patch + therapy. Game-changer for tobacco smoking addiction?
Doctors Still Beat AI on Practicality and Cost
Comparison of AI and primary care physicians for 100 patients in a prospective real-world assessment —The physicians outperformed AI [AIME] for practicality and cost-effectiveness —AI was comparable for diagnosis, management plan, appropriateness and safety @AdamRodmanMD @alan_karthi @PeterBrodeurMD @googledeepmind https://t.co/FNWYoHVkkw
Blood Test Predicts Alzheimer's up to 25 Years Early
Predicting Alzheimer's disease up to 25 years in advance of any symptoms with the p-tau217 biomarker blood test, among 2,766 women mean age 70 https://t.co/aOActAUN27 https://t.co/Bxl2YZxnlf
Long
But hey, it’s all in our heads, amirite? (And for those who think this is all vax-induced: Bear in mind that the majority of long-haulers came from wave one, pre-vaccine.) https://t.co/wykHr4y0tX
AI Proven to Boost Breast Cancer Screening Accuracy
3 new reports and an editorial @NatureCancer reinforce the benefit of AI for breast cancer screening https://t.co/MlFns7M0yB https://t.co/MF3fj0CuIE https://t.co/a436srKDaD https://t.co/1XTMIsAPfg
DNA Repair Mutations Predict Response to Chemo‑Immunotherapy in Pancreatic Cancer
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma https://t.co/v39bOreJwu
FDA Adds Six Former Members, Total Nine Voters
Correction: I took down a post about Thursday's #VRBPAC meeting because it contained an error. #FDA has named 6 temporary voting members (not 2), which will bring the number for the meeting to 9. The temps are all former members....
FDA Accepts CAPR's Deramiocel Resubmission, Decision Aug 22
$CAPR resubmission of the deramiocel application accepted by the FDA. New decision date: Aug. 22. https://t.co/mWSyyXg8di
CRISPR's Natural Blueprint Powers Gene‑Therapy Breakthroughs
How CRISPR works (in nature) and how it’s being leveraged as a tool for gene editing to cure and prevent diseases. Dr Alex Marson MD PhD of UCSF on the Huberman Lab podcast out now. https://t.co/fiL48JHxSL
Medicare Advantage Overpayments Add $13.4B to Seniors' Premiums
“Overpayments to Medicare Advantage insurers increased Part B premiums by $13.4 billion in 2025, the committee said, a cost mostly borne by seniors.”
GSK Secures Approval Yet Refuses to Produce Drug
$GSK is ostensibly the "sponsor" that won the approval but is once again saying it won't produce the drug.